Tizanidine Hcl Tablet
Product Images NDC 80425-0022

6 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine Hcl (NDC 80425-0022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1

Figure 1
A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. The graph compares 4 mg Tizanidine tablets and capsules taken with and without food, illustrating concentration-time profiles up to 24 hours post-dose with separate lines for each condition.*
FDA Label Image

Figure 2

Figure 2
A line graph showing improvement in Ashworth Score over time post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The x-axis represents hours post-dose from 0 to 6, and the y-axis represents improvement in Ashworth Score ranging from -5 to 0. The graph includes error bars for variability in the data.*
FDA Label Image

Figure 3

Figure 3
A line plot comparing improvement in Ashworth Score over time between Tizanidine at a mean dose of 28.8 mg and placebo. The x-axis marks three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis shows improvement in Ashworth Score, with negative values indicating greater improvement. Markers represent mean scores with error bars for variability.*
FDA Label Image

Structure

Structure
Chemical structure diagram of Tizanidine HCL showing its molecular arrangement including chlorine, nitrogen, sulfur atoms, and hydrogen chloride (HCl) components.*
FDA Label Image

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0022

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0022
Tizanidine HCL 4 mg oral tablets, bottle with 90 tablets, labeled with NDC 80425-0022 by Advanced Rx of Tennessee, LLC. The label includes lot number 90T11242121, expiration date 1/1/2022, and storage instructions to keep at room temperature 20°C to 25°C (68°F to 77°F). A barcode and QR code are visible on the label.*
FDA Label Image

Tizanidine HCl 4mg Tab Qty 60 Ndc 80425 0022

Tizanidine HCl 4mg Tab Qty 60 Ndc 80425 0022
The packaging label for Tizanidine HCL 4 mg oral tablets, bottle of 60 count, by Advanced Rx of Tennessee, LLC. It includes a comparison to Tizanil EZ, with lot number G0T1241221 and expiration date 1/1/2022. Storage instructions recommend room temperature from 20 to 25°C (68 to 77°F). A barcode and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.